title: [Multiple value of sumatriptan above that of ergot alkaloids still not proven].
authors.forename: M D
authors.initials: MD
authors.lastname: Ferrari
authors.forename: J
authors.initials: J
authors.lastname: Haan
authors.forename: W
authors.initials: W
authors.lastname: Bax
authors.forename: R S
authors.initials: RS
authors.lastname: van Coevorden
authors.forename: J A
authors.initials: JA
authors.lastname: van Huijgevoort
authors.forename: H
authors.initials: H
authors.lastname: Timmerman
authors.forename: W J
authors.initials: WJ
authors.lastname: Meyler
mesh_terms: D004878:Ergotamine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D018170:Sumatriptan / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D018170:Sumatriptan; D004878:Ergotamine
vernacular_title: Meerwaarde van sumatriptan boven ergot-alkaloïden nog steeds niet aangetoond.